BH4
Showing 1 - 25 of 2,762
BH4 Blood Levels Variations in Pre Eclamptic Women
Recruiting
- Pre Eclampsia
- +4 more
- BH4 blood level
-
Tunis, TunisiaTunis maternity and neonatology center, minisetry of public heal
Apr 26, 2023
Phenylketonuria Trial in Galveston (tetrahydrobiopterin (BH4))
Terminated
- Phenylketonuria
- tetrahydrobiopterin (BH4)
-
Galveston, TexasUniversity of Texas Medical Branch
Sep 20, 2021
Endothelial Dysfunction Trial in Hackensack (Sapropterin DiHCl, Sapropterin DiHCl and Vitamin C)
Completed
- Endothelial Dysfunction
- Sapropterin Dihydrochloride
- Sapropterin Dihydrochloride and Vitamin C
-
Hackensack, New Jersey(unnamed)
Apr 22, 2021
Radiation Enteritis Trial in Chengdu (Tetrahydrobiopterin)
Recruiting
- Radiation Enteritis
-
Chengdu, Sichuan, Chinaest China Second Hospital of Sichuan University
Feb 25, 2022
Phenylketonuria Trial in Cleveland (saproterin diHCl, Diet treatment)
Completed
- Phenylketonuria
- saproterin dihydrochloride
- Diet treatment
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center
Apr 26, 2022
Heart Failure With Reduced Ejection Fraction Trial in Salt Lake City (Antioxidant, Tetrahydrobiopterin (BH4), Exercise training)
Recruiting
- Heart Failure With Reduced Ejection Fraction
- Antioxidant
- +2 more
-
Salt Lake City, UtahVA Salt Lake City Health Care System, Salt Lake City, UT
Jun 17, 2022
Head and Neck Squamous Cell Carcinoma Trial (Sapropterin diHCl tablets)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Sapropterin dihydrochloride tablets
- (no location specified)
Mar 17, 2022
COPD, Pulmonary Artery Hypertension, Heart Failure Trial in Salt Lake City (Maximum Exercise Tests, BH4, L-NMMA, Vitamin C,
Recruiting
- Chronic Obstructive Pulmonary Disease
- +3 more
- Maximum Exercise Tests
- +6 more
-
Salt Lake City, UtahGeorge E Wahlen VA Medical Center
Sep 15, 2021
Peripheral Artery Disease, Peripheral Arterial Disease Trial (Sapropterin DiHCl (BH4, tetrahydrobiopterin), Placebo)
Withdrawn
- Peripheral Artery Disease
- Peripheral Arterial Disease
- Sapropterin Dihydrochloride (BH4, tetrahydrobiopterin)
- Placebo
- (no location specified)
Nov 24, 2020
Dipeptidyl-4 Inhibitors in Reducing Stroke Severity, From HIRA
Not yet recruiting
- Cerebral Infarction
- +2 more
- Dipeptidyl peptidase-4 inhibitor
- (no location specified)
Apr 5, 2023
Deep Vein Thrombosis Trial in Poole (geko™ post-surgery for 48hrs then 4hrs/day until discharge., TEDS post-surgery for 48hrs
Completed
- Deep Vein Thrombosis
- geko™ post-surgery for 48hrs then 4hrs/day until discharge.
- TEDS post-surgery for 48hrs then 4hrs/day until discharge.
-
Poole, Dorset, United KingdomBMI The Harbour Hospital
Aug 4, 2022
Sickle Cell Disease Trial in United States (Sapropterin DiHCl)
Completed
- Sickle Cell Disease
- Sapropterin Dihydrochloride
-
Washington, District of Columbia
- +11 more
Feb 3, 2021
Hyperphenylalaninemia (HPA) Due to Phenylketonuria (PKU) or Tetrahydrobiopterin (BH4) Deficiency Trial in Worldwide
Completed
- Hyperphenylalaninemia (HPA) Due to Phenylketonuria (PKU) or Tetrahydrobiopterin (BH4) Deficiency
-
Graz, Austria
- +68 more
Apr 14, 2022
Rheumatologic Disease Trial in Salt Lake City (BH4, Vasculopathy assessment, Placebo)
Completed
- Rheumatologic Disease
- BH4
- +2 more
-
Salt Lake City, UtahVA Salt Lake City Health Care System, Salt Lake City, UT
Apr 1, 2021
Tetrahydrobiopterin Deficiencies, Hyperphenylalaninemia, Non-Phenylketonuric Trial in Germany, United States (Phenoptin)
Completed
- Tetrahydrobiopterin Deficiencies
- Hyperphenylalaninemia, Non-Phenylketonuric
-
Los Angeles, California
- +9 more
Sep 24, 2020
COPD (COPD) Trial in Augusta (Tetrahydrobiopterin (BH4), Antioxidant Cocktail)
Completed
- Chronic Obstructive Pulmonary Disease (COPD)
- Tetrahydrobiopterin (BH4)
- Antioxidant Cocktail
-
Augusta, GeorgiaGeorgia Prevention Institute
Feb 5, 2021
Phenylketonuria Trial in Canada, United States (sapropterin diHCl)
Completed
- Phenylketonuria
- sapropterin dihydrochloride
-
La Jolla, California
- +18 more
Dec 1, 2020
Venous Leg Ulcer, Leg Ulcers Venous, Leg Ulcer Trial in United Kingdom (geko™ medical device)
Active, not recruiting
- Venous Leg Ulcer
- +4 more
- geko™ medical device
-
Southsea, Portsmouth, United Kingdom
- +22 more
Aug 4, 2022
Coronary Artery Disease Trial in Worldwide (CT-guided PCI, IVUS-guided PCI)
Recruiting
- Coronary Artery Disease
- CT-guided PCI
- IVUS-guided PCI
-
Jette, Brussels, Belgium
- +13 more
May 30, 2022
Secondary Progressive Multiple Sclerosis (SPMS) Trial in United Kingdom (Simvastatin, Placebo)
Active, not recruiting
- Secondary Progressive Multiple Sclerosis (SPMS)
- Simvastatin
- Placebo
-
Belfast, United Kingdom
- +23 more
Jul 4, 2022
Malignant Biliary Obstruction Trial in Bournemouth, Manchester (Intraductal Radio-Frequency Ablation, Biliary Stent Placement)
Not yet recruiting
- Malignant Biliary Obstruction
- Intraductal Radio-Frequency Ablation
- Biliary Stent Placement
-
Bournemouth, Dorset, United Kingdom
- +1 more
May 16, 2022
Chronic Lymphocytic Leukemia Trial in Poland, United Kingdom (Ceralasertib, Acalabrutinib)
Active, not recruiting
- Chronic Lymphocytic Leukemia
-
Kraków, Poland
- +10 more
Dec 2, 2022